Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial
ConclusionThe tested nutraceutical association is able to improve the positive effects of a Mediterranean diet on a large number of CV risk factors and consequently of the estimated CV risk.Trial registrationClinicalTrials.gov identifier NCT02492464.FundingIBSA Farmaceutici.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Clinical Trials | Diets | Drugs & Pharmacology | Fatty Liver Disease (FLD) | Heart | Liver | Nutrition | Red Yeast Rice | Urology & Nephrology